Cyclo Therapeutics Provides Business Update And Reports FY22 Financial Results; The Company Ended The Year With ~$1.5M Of Cash. Pro-forma Year End Cash Of $5.2M Post The Financing Completed On With Single Institutional Investor In January Of 2023

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!